RUNX2 and cleidocranial dysplasia 1: A spectrum of severity of CCD symptoms is correlated with the extent of transcriptional activity remaining in the cognate mutant RUNX2 with severest symptoms associated with complete loss of RUNX2 function [19] and milder symptoms correlated with some residual RUNX2 transactivation function [20].